Rajinikanth undergoes surgical procedure, to be discharged in a few days
Chennai
29-October-2021

PHOTO: IANS
Megastar Rajinikanth successfully underwent a surgical procedure called Carotid Artery Revascularisation at a hospital here on Friday.
The actor is recovering well and is likely to be discharged in a few days, said a top official of the Kauvery Hospital.
Rajinikanth was admitted to Kauvery Hospital here on Thursday following an episode of giddiness.
"He was thoroughly evaluated by the expert panel of doctors and was advised to undergo Carotid Artery Revascularisation, said Dr Aravindan Selvaraj, co-founder and Executive Director, in a statement.
"The procedure was performed successfully today (October 29) and he is recovering well. He is likely to be discharged from the hospital after a few days," Dr Selvaraj added.
Rajinikanth, who was awarded the Dadasaheb Phalke Award on Thursday, had tweeted that he had watched his yet-to-be released movie 'Annatthe' with his grandson on Wednesday.
Last year, Rajinikanth decided against taking a much-awaited political plunge citing his health condition.
Watch This TWL Video
At that time, Rajinikanth said the doctors had advised him that fluctuating blood pressure would affect his transplanted kidney - IANS
More Headlines
Junior Chidambaram Calls For Urban-Focused Political Outfit, Free Of Identity Politics
Uddhav and Raj Thackeray May Unite for Protest Against Hindi Imposition
With Govt Help and Good Prices, Dragon Fruit Turns into a Profitable Crop
Ex-DGP To Join Probe Into Akali Leader Majithia's Rs 540 Crore Drug Money Laundering Case
Villa Rental Platform StayVista Raises Over Rs 40 Crore in Series B Round
Junior Chidambaram Calls For Urban-Focused Political Outfit, Free Of Identity Politics
Uddhav and Raj Thackeray May Unite for Protest Against Hindi Imposition
With Govt Help and Good Prices, Dragon Fruit Turns into a Profitable Crop
Ex-DGP To Join Probe Into Akali Leader Majithia's Rs 540 Crore Drug Money Laundering Case
Villa Rental Platform StayVista Raises Over Rs 40 Crore in Series B Round